Use of Statins and the Subsequent Development of Deep Vein Thrombosis
Archives of Internal MedicinePublished 11 June 2001
Joel G. Ray, Mohammed Mamdani, Ross T. Tsuyuki, David R. Anderson, Erik Yeo, Andreas Laupacis
Citations205
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A retrospective cohort study over an 8-year period found that among selected individuals aged 65 years or older, statins were associated with a 22% relative risk reduction in the risk of DVT.
Abstract
Among selected individuals aged 65 years or older, statins were associated with a 22% relative risk reduction in the risk of DVT. A randomized clinical trial is needed to evaluate the efficacy of statins for the primary and secondary prevention of DVT.
Keywords
Medicine
New England Journal of MedicinePrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
7,453 Citations1995James Shepherd, Stuart M. Cobbe +6 more
Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of my Cardiac Infarction.
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
3,460 Citations1995J Ames S Hepherd, S Tuart M. C Obbe +7 more
Archives of Internal MedicineRisk Factors for Deep Vein Thrombosis and Pulmonary Embolism
2,173 Citations2000John A. Heit, Marc D. Silverstein +4 more
Hospital or nursing home confinement, surgery, trauma, malignant neoplasm, chemotherapy, neurologic disease with paresis, central venous catheter or pacemaker, varicose veins, and superficial vein thrombosis are independent and important risk factors for VTE.
New England Journal of MedicineA Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism
1,069 Citations1999Clive Kearon, Michael Gent +20 more
Patients with a first episode of idiopathic venous thromboembolism should be treated with anticoagulant agents for longer than three months, according to a prespecified interim analysis of efficacy.
The LancetPrevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
1,069 Citations2000Pulmonary Embolism Prevention (PEP) trial Collaborative Group
Results show that aspirin reduces the risk of pulmonary embolism and deep-vein thrombosis by at least a third throughout a period of increased risk, and there is now good evidence for considering aspirin routinely in a wide range of surgical and medical groups at high risk of venous thromboembolism.
New England Journal of MedicineThe Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts
970 Citations1997The Post Coronary Artery Bypass Graft Trial Investigators
Aggressive lowering of LDL cholesterol levels to below 100 mg per deciliter reduced the progression of atherosclerosis in grafts and low-dose warfarin did not reduce the progression in patients with aortocoronary bypass grafts.
Journal of Internal MedicineA prospective study of the incidence of deep‐vein thrombosis within a defined urban population
784 Citations1992Marie Nordström, Bengt Lindblad +2 more
In a prospective study all positive phlebographies within the well‐defined population of the city of MalmÖ, Sweden, during 1987 were studied in order to determine the incidence of deep venous thrombosis (DVT), and risk factors were found to be in accordance with earlier studies.
Annals of Internal MedicinePostmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study
714 Citations2000Deborah Grady, Nanette K. Wenger +6 more
The Heart and Estrogen/progestin Replacement Study was a randomized, blinded, placebo-controlled trial of the effect of daily conjugated equine estrogen on the rate of new coronary events in postmenopausal women with established coronary heart disease and one of the specified secondary outcomes of this trial was venous thromboembolism.
JAMAPersistence of Use of Lipid-Lowering Medications
639 Citations1998Jerry Avorn, Johanne Monette +5 more
New England Journal of MedicineThe Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism
611 Citations1997Sam Schulman, S. Granqvist +14 more
Prophylactic oral anticoagulation that was continued for an indefinite period after a second episode of venous thromboembolism was associated with a much lower rate of recurrence during four years of follow-up than treatment for six months, however, there was a trend toward a higher risk of major hemorrhage when antICOagulation was continued indefinitely.
Archives of Internal MedicineThe Epidemiology of Diagnosed Pulmonary Embolism and Deep Venous Thrombosis in the Elderly
516 Citations1994Wayne D. Kniffin
Current treatment patterns appear to be effective in preventing both PE after treatment for DVT and recurrence of PE, suggesting the need to understand the role of associated conditions as well as the indications for prophylaxis and the methods of treatment.
Annals of Internal MedicineThe Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism
486 Citations1998Clive Kearon, Jeffrey S. Ginsberg +1 more
The strengths and weaknesses of venous ultrasonography are considered in patients with the five clinical presentations of suspected venous thromboembolism and the criteria used to diagnose thrombosis often vary among examiners.
JAMAComorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality?
451 Citations1992Lisa I. Iezzoni
Annals of Internal MedicineEffect of Pravastatin on Cardiovascular Events in Older Patients with Myocardial Infarction and Cholesterol Levels in the Average Range: Results of the Cholesterol and Recurrent Events (CARE) Trial
433 Citations1998Sandra J. Lewis, Lemuel A. Moye +11 more
The Cholesterol and Recurrent Events (CARE) trial investigated whether reducing average cholesterol levels by using pravastatin in patients who have had myocardial infarction would prevent recurrent cardiac events, and reported that patients who were older than the median age of 59 years had a reduced rate of coronary death, nonfatal myocardIAL infarctions, coronary artery bypass grafting, angioplasty, and stroke.
Journal of the American Geriatrics SocietyAssessment and Control for Confounding by Indication in Observational Studies
350 Citations1999Bruce M. Psaty, Thomas D. Koepsell +6 more
Understanding the methods to detect and control for confounding makes it possible to assess the plausibility of claims that confounding is an alternative explanation for the findings of particular studies.
CirculationIncreased Lipoprotein(a) Is an Important Risk Factor for Venous Thromboembolism in Childhood
227 Citations1999Ulrike Nowak‐Göttl, Ralf Junker +5 more
The little-characterized role of Lp(a) as a risk factor for venous thromboembolic diseases, alone and in conjunction with established thrombophilic risk factors of proteins regulating blood coagulation and fibrinolysis is investigated.
The Medical Journal of AustraliaApparent discontinuation rates in patients prescribed lipid‐lowering drugs
213 Citations1996Leon A. Simons, Graham Levis +1 more
Evaluation of apparent discontinuation rates in patients newly prescribed lipid‐lowering drugs finds no clear pattern in response to lipid-lowering medications.
AtherosclerosisThe atherogenic lipoprotein phenotype and vascular endothelial dysfunction
164 Citations1998Naveed Sattar, John R. Petrie +1 more
There is accumulating evidence that elevated plasma triglycerides and related abnormalities constitute an independent cardiovascular risk factor and there is recent strong evidence to suggest that increased postprandial circulating concentrations of triglyceride-rich particles and remnant particles may be deleterious to the endothelium.
Journal of the American College of CardiologyInhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia
130 Citations1999Andrzej Szczeklik, Jacek Musiał +5 more
The LancetEffects of pravastatin in 3260 patients with unstable angina: results from the LIPID study
89 Citations2000Andrew Tonkin, David Colquhoun +10 more
In patients with previous unstable angina, coronary heart disease mortality, total mortality, myocardial infarction, a need for coronary revascularisation, the number of admissions to hospital, and theNumber of days in hospital were significantly lower with pravastatin.
Thrombosis ResearchHYPERCHOLESTEROLEMIA AS A RISK FACTOR FOR DEEP-VEIN THROMBOSIS
85 Citations1997Tomio Kawasaki, J. Kambayashi +4 more
The hypothesis that hypercholesterolemia plays an important role in the pathogenesis of DVT is supported by the findings of a case-control study.
PubMedPostmenopausal estrogen replacement therapy and increased rates of cholecystectomy and appendectomy.
46 Citations2000Muhammad Mamdani, Karen Tu +3 more
Those who had recently begun taking estrogen were significantly more likely to undergo cholecystectomy and appendectomy among postmenopausal women who have recently begun estrogen replacement therapy.
Thrombosis and HaemostasisFemale Gender and Resistance to Activated Protein C (FV:Q506) as Potential Risk Factors for Thrombosis after Elective Hip Arthroplasty
39 Citations1997P Svensson, G Benoni +7 more
It is suggested that prolonged prophylaxis with LMWH after hip surgery is more important for women than for men, and the uneven distribution of APC-resistance between men and women, taken together with the increased risk of thrombosis among women, precluded valid conclusions to be drawn.
The American Journal of CardiologyGender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin
35 Citations1999George Dangas, Donald A. Smith +8 more
Despite higher HDL, and lower incidence of coronary disease, women with high LDL had a comparable thrombotic and/or fibrinolytic profile to men and even evidence of increased thrombin generation at baseline.
Baillière s Clinical Haematology2 Diagnostic management of venous thromboembolism
33 Citations1998Roderik A. Kraaijenhagen, Anthonie W.A. Lensing +4 more
It seems safe to withhold anticoagulant therapy in patients suspected of pulmonary embolism with a normal perfusion lung scan result, and D-dimer assays, clinical decision rules and ultrasound examinations of the legs seem to have a high potential to limit the need for angiography.
Pathophysiology of Haemostasis and ThrombosisStatins as Cellular Antithrombotics
30 Citations1999John W. Fenton, Garry X. Shen
It is hypothesize that statins exhibit antithrombotic properties at the cellular level downregulatating IIa generation and that statin may constitute a novel class of antithromabotics.
Thrombosis and HaemostasisFluvastatin Decreases Soluble Thrombomodulin in Cardiac Transplant Recipients
30 Citations2000Marie-Françoise Aillaud, Gilbert Habib +6 more
Fluvastatin treatment had no significant effect on creatininemia, plasma cyclosporine, PAI-1 antigen, PAi-1 activity, tPA antigen, and Von Willebrand factor, but produced a significant decrease of plasma thrombomodulin, suggesting a rapid improvement of endothelial injury in these patients.
The American Journal of CardiologyEffects of fluvastatin on prothrombotic and fibrinolytic factors in type 2 diabetes mellitus
26 Citations1999K. C. B. Tan, Edward Janus +1 more
The effects of fluvastatin therapy on parameters of coagulation and fibrinolysis were evaluated in patients with diabetic dyslipidemia in a randomized, placebo-controlled study and the effects were much less marked than its effects on plasma lipids.